Upexi to Host First Quarter 2026 Earnings Call on November 11th at 5:30 p.m. ET GlobeNewswire November 06, 2025 TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference […]
Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors GlobeNewswire November 06, 2025 Exclusive collaboration and license agreement focuses on advancing novel T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the CUE-100 series of Immuno-STATs(R) Novel therapeutic approach is designed to enable in vivo expansion and activation
Feed a Family of 10 for Under $40 this Thanksgiving: Stop & Shop Introduces One of the Season's Best Dinner Deals With a competitive meal deal, a Lowest Price Guarantee on turkeys, and savings all month long, better value starts at Stop & Shop this holiday season GlobeNewswire November 06, 2025 QUINCY, Mass., Nov. 06,
LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced financial results for the third quarter ended on September 30, 2025 and provided recent corporate updates. “Following our recent initial
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights GlobeNewswire November 06, 2025 Reported positive topline results from the Phase 2 Avail(TM) trial of once-weekly canvuparatide in hypoparathyroidism (HP) Completed upsized public offering, raising approximately $200 million in gross proceeds $391.7 million in cash, cash equivalents and marketable securities as of September
Raise Craze, a partnership between the MUHC Foundation, The Beat 92.5, and Pink in the City, raised $162,160 for breast cancer care at the MUHC GlobeNewswire November 06, 2025 MONTREAL, Nov. 06, 2025 (GLOBE NEWSWIRE) — During October's Breast Cancer Awareness Month, the MUHC Foundation once again partnered with The Beat 92.5 and Pink in
Dare Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025 GlobeNewswire November 06, 2025 SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — DareÌ Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025 GlobeNewswire November 06, 2025 DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the quarter ended September
Imbria Pharmaceuticals Announces First Patient Randomized in FORTITUDE-HCM Phase 2b Clinical Trial Evaluating Ninerafaxstat for Non-Obstructive Hypertrophic Cardiomyopathy GlobeNewswire November 06, 2025 Advances development of ninerafaxstat, a potential first-in-class therapy designed to improve cardiac energetics in patients with serious cardiovascular diseases Enrollment underway across U.S. sites with U.K. and EU expansion anticipated by end of
iOThree Limited Announces 1-for-10 Reverse Share Split GlobeNewswire November 06, 2025 Singapore, Nov. 06, 2025 (GLOBE NEWSWIRE) — iOThree Limited (Nasdaq: IOTR, the “Company”), today announced that the shareholders and the board of directors of the Company approved a one-for-ten reverse share split of the Company's issued and unissued ordinary shares (the “Ordinary Shares”), class